![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, February 09, 2010 6:24:12 PM
I get the sense they (The FDA) know they have a bad image and what appear to be weak process but hopefully they taking steps to improve and get things in motion which should be good for Imaging3, the Product's before the FDA and the Stock.
It can't get too much worse and it sounds like some big changes at the top and some other processes are being introduced to move things along such as this which is combining Trial Data to shorten approval times. As I said it can't hurt and anything that highlight's the issues and reduces the approval times is a good thing and hopefully works in Imaging3 favor along with other companies who may past the approval process.
Go IMGG!
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM